Left ventricular hypertrabeculation/noncompaction as a cardiac manifestation of Duchenne muscular dystrophy under non-invasive positive-pressure ventilation

Acta Cardiologica

Volumn 60, Issue 4, 2005, Pages 445-448

  Finsterer, Josef ^a,c   Gelpi, Ellen ^b   Stöllberger, Claudia ^a  

^a KRANKENANSTALT RUDOLFSTIFTUNG   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c NONE   (Austria)

Author keywords

Cardiac involvement; Heart failure; Muscular dystrophy; Myocardium; Neuromuscular disorder; Non invasive ventilation; Rhythm abnormalities

Indexed keywords

AMIODARONE; BISOPROLOL;

ADULT; ANISOCORIA; ARTERY DIAMETER; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DUCHENNE MUSCULAR DYSTROPHY; ECHOCARDIOGRAPHY; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART FAILURE; HUMAN; HUMAN TISSUE; HYPERTHYROIDISM; LABORATORY TEST; LEFT VENTRICULAR HYPERTRABECULATION/NONCOMPLICATION; MALE; MITRAL VALVE REGURGITATION; MYOCARDIAL DISEASE; NEUROLOGIC EXAMINATION; POSITIVE END EXPIRATORY PRESSURE;

EID: 23644452964     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: 10.2143/AC.60.4.2004996     Document Type: Article

References (21)

1. Stollberger C, Finsterer J. Left ventricular hypertrabeculation/ noncompaction. J Am Soc Echocardiogr 2004; 17: 91-100.
2. Stöllberger C, Finsterer J, Blazek G. Left ventricular hypertrabeculation/non-compaction and association with additional cardiac and neuromuscular disorders. Am J Cardiol 2002; 90; 899-902.
3. Yue Y, Li Z, Harper SQ, Davisson RL, Chamberlain JS, Duan D. Microdystrophin gene therapy of cardiomyopathy restores dystrophin-glycoprotein complex and improves sarcolemma integrity in the mdx mouse heart. Circulation 2003; 108: 1626-32.
4. Janssen B, Hartmann C, Scholz V, Jauch A, Zschocke J. MLPA analysis for the detection of deletions, duplications and complex rearrangements in the dystrophin gene: potential and pitfalls. Neurogenetics 2005; 6: 29-35.
5. Ishihara T. Cardiopulmonary failure in Duchenne muscular dystrophy - pathophysiology and management. Rinsho Shinkeigaku 2003; 43: 761-4.
6. Pellegrini N, Guillon B, Prigent H, Pellegrini M, Orlikovski D, Raphael JC, Lofaso F. Optimization of power wheelchair control for patients with severe Duchenne muscular dystrophy. Neuromuscul Disord 2004; 14: 297-300.
7. Lohan J, Ohlendieck K. Drastic reduction in the luminal Ca2+-binding proteins calsequestrin and sarcalumenin in dystrophin-deficient cardiac muscle. Biochim Biophys Acta 2004; 1689: 252-8.
8. Danzig V, Fiksa J, Hani AB, Havlova M, Sonka K. Cardiac problems in patients with progressive muscular dystrophy. Sb Lek 2003; 104: 273-8.
9. Chin TK, Perloff JK, Williams RG, Joe K, Muhrmann R. Isolated noncompaction of the left ventricular myocardium. A study of eighth cases. Circulation 1990; 82: 507-13.
10. Agnisola C, Tota B. Structure and function of the fish cardiac ventricle: Flexibility and limitations. Cardioscience 1994; 5: 145-53.
11. Peters NS, Severs NJ, Rothery SM, Lincoln C, Yacoub MH, Green CR. Spatiotemporal relation between gap junctions and fascia adherens junctions during postnatal development of human ventricular myocardium. Circulation 1994; 90: 713-25.
12. Bogaert J, Rademakers FE. Regional nonuniformity of normal adult human left ventricle. Am J Physiol Heart Circ Physiol 2001; 80: 610-20.
13. Stöllberger C, Finsterer J, Blazek G, Bittner RE. Left ventricular non-compaction in a patient with Becker's muscular dystrophy. Heart 1996; 76: 380.
14. Finsterer J, Schoser B, Stöllberger C. Myoadenylate-deaminase gene mutation associated with left ventricular hypertrabeculation. Acta Cardiol 2004; 59: 453-6.
15. Finsterer J, Stöllberger C, Jarius C, Wegmann R, Janssen B. Left ventricular hypertrabeculation in myotonic dystrophy type 1. Herz 2001; 26: 287-90.
16. Vatta M, Mohapatra B, Jimenez S, Sanchez X, Faulkner G, Perles Z, Sinagra G, Lin JH, Vu TM, Zhou Q, Bowles KR, Di Lenarda A, Schimmenti L, Fox M, Chrisco MA, Murphy RT, McKenna W, Elliott P, Bowles NE, Chen J, Valle G, Towbin JA. Mutations in Cypher/ZASP in patients with dilated cardiomyopathy and left ventricular non-compaction. J Am Coll Cardiol 2003; 42: 2014-27.
17. Ichida F, Tsubata S, Bowles KR, Haneda N, Uese K, Miyawaki T, Dreyer WJ, Messina J, Li H, Bowles NE, Towbin JA. Novel gene mutations in patients with left ventricular noncompaction or Barth syndrome. Circulation 2001; 103: 1256-63.
18. Finsterer J, Stöllberger C. Hypertrabeculated left ventricle in mitochondriopathy. Heart 1998; 80: 632.
19. Bleyl SB, Mumford BR, Brown-Harrison M-C, Pagotto LT, Carey JC, Pysher TJ, Ward K, Chin TK. Xq28-linked noncompaction of the left ventricular myocardium: Prenatal diagnosis and pathologic analysis of affected individuals. Am J Med Genet 1997; 72: 257-65.
20. Pipo JR, Feng JH, Yamamoto T, Ohsaki Y, Nanba E, Tsujino S, Sakuragawa N, Martiniuk F, Ninomiya H, Oka A, Ohno K. New GAA mutations in Japanese patients with GSDII (Pompe disease). Pediatr Neurol 2003; 29: 284-7.
21. Alper G, Narayanan V. Friedreich's ataxia. Pediatr Neurol 2003; 28: 335-41.